Frankfurt Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.30 M
as on 23-10-2024
- Paid Up Capital ₹ 0.10 M
as on 23-10-2024
- Company Age 20 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 8.84%
(FY 2023)
- Profit 174.85%
(FY 2023)
- Ebitda 33.89%
(FY 2023)
- Net Worth 6.43%
(FY 2023)
- Total Assets -2.61%
(FY 2023)
About Frankfurt Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.30 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Manish Sharma, Sunil Bhat, and Rakesh Raina serve as directors at the Company.
- CIN/LLPIN
U24232DL2004PTC127496
- Company No.
127496
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Jul 2004
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Frankfurt Pharmaceuticals?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Manish Sharma  | Director | 19-Jul-2004 | Current |
| Sunil Bhat | Director | 19-Jul-2004 | Current |
| Rakesh Raina | Director | 19-Jul-2004 | Current |
Financial Performance of Frankfurt Pharmaceuticals.
Frankfurt Pharmaceuticals Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 8.84% increase. The company also saw a substantial improvement in profitability, with a 174.85% increase in profit. The company's net worth moved up by a moderate rise of 6.43%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Frankfurt Pharmaceuticals?
In 2022, Frankfurt Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Frankfurt Pharmaceuticals?
Frankfurt Pharmaceuticals has a workforce of 15 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Frankfurt Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Frankfurt Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
